Hikma Ventures
Overview
Hikma Ventures is the corporate venture capital arm of Hikma Pharmaceuticals, a British multinational pharmaceutical company. Established in 2015, it invests globally in emerging digital health and life sciences companies. The firm focuses on areas such as drug delivery, digital therapeutics, clinical trial innovation, respiratory, CNS, and oncology. While stage-agnostic, it shows a preference for Series A and B rounds.
Portfolio Companies
9
Website
hikma.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Octave Bioscience | Sep 2025 | Series C | Co-investor |
| Rakuten Medical | Mar 2024 | Series E | Lead |
| Prognos Health | May 2023 | Growth Equity | Co-investor |
| Tact | Mar 2022 | Strategic | - |
| Activ Surgical | Mar 2022 | Series B Extension | Lead |
Key People
Hulesy Britt
Managing Partner
Abdullah Ahmad
Managing Director Iraq Market At Hikma Pharmaceuticals
B H
Managing Director
Hussein Alsafadi
Manager, People Partner - Corporate
O. ZITOUNI
People Manager Partner
Sabreen Mukahal
Manager, People Partner
Amer Naouri
Sr. IT Director - Business Technology Partner
MSc HRMD Mohammad T. Al Majali
Associate Director, People Partner
Ana Silva
Principal, Pharmaceutical Development
Anas Zaghal
Principal Scientist R D
Ashish Chokshi
Principal Scientist
Balaji Narimeta
Principal Architect MDG IT
Bikash Mondal
Principal Scientist
Claire Navarro
Principal Scientist
Dima Freihat
Principal Scientist
Dongyun Liu
Principal Scientist, Formulation Development
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
